Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:33 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 544122 | NSE: ENTERO

Entero Healthcare Solutions Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹869.18Overvalued by 30.30%vs CMP ₹1,247.00

P/E (46.6) × ROE (5.6%) × BV (₹406.00) × DY (2.00%)

₹941.93Overvalued by 24.46%vs CMP ₹1,247.00
MoS: -32.4% (Negative)Confidence: 54/100 (Moderate)Models: 1 Under, 1 Fair, 6 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹2,203.1027%Under (+76.7%)
Graham NumberEarnings₹486.5116%Over (-61%)
DCFCash Flow₹642.7013%Over (-48.5%)
Net Asset ValueAssets₹406.249%Over (-67.4%)
EV/EBITDAEnterprise₹364.8611%Over (-70.7%)
Earnings YieldEarnings₹259.109%Over (-79.2%)
ROCE CapitalReturns₹71.139%Over (-94.3%)
Revenue MultipleRevenue₹1,171.597%Fair (-6%)
Consensus (8 models)₹941.93100%Overvalued
Key Drivers: EPS CAGR 153.5% lifts DCF — verify sustainability. | Wide model spread (₹71–₹2,203) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 153.5%

*Investments are subject to market risks

Investment Snapshot

58
Entero Healthcare Solutions Ltd scores 58/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health55/100 · Moderate
ROCE 8.7% AverageROE 5.6% WeakD/E -4.46 Low debtInterest Coverage 0.0x RiskyProfitable 2/5 years Inconsistent
Smart Money45/100 · Moderate
FII holding down -14.78% (6mo) SellingDII holding up 6.79% MF buyingPromoter holding at 52.4% Stable
Earnings Quality50/100 · Moderate
OPM stable around 3% Steady
Quarterly Momentum90/100 · Strong
Revenue (4Q): +26% YoY AcceleratingProfit (4Q): +36% YoY Strong
Industry Rank40/100 · Moderate
P/E 46.6 vs industry 53.8 In-lineROCE 8.7% vs industry 16.4% Below peersROE 5.6% vs industry 15.2% Below peers3Y sales CAGR: 26% High growth

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:33 am

Market Cap 5,424 Cr.
Current Price 1,247
Intrinsic Value₹941.93
High / Low 1,511/944
Stock P/E46.6
Book Value 406
Dividend Yield0.00 %
ROCE8.71 %
ROE5.63 %
Face Value 10.0
PEG Ratio0.30

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Entero Healthcare Solutions Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Entero Healthcare Solutions Ltd 5,424 Cr. 1,247 1,511/94446.6 4060.00 %8.71 %5.63 % 10.0
FDC Ltd 5,345 Cr. 328 528/31323.0 1491.52 %15.9 %11.8 % 1.00
Aarti Pharmalabs Ltd 5,757 Cr. 635 972/55726.7 2260.79 %17.4 %14.5 % 5.00
Blue Jet Healthcare Ltd 6,089 Cr. 351 1,028/32520.7 72.40.34 %39.8 %30.2 % 2.00
Suven Life Sciences Ltd 3,888 Cr. 147 303/115 12.40.00 %87.0 %87.2 % 1.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Entero Healthcare Solutions Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 8298878999969931,0341,0971,3011,3591,3391,4041,5711,707
Expenses 8108678739689641,0051,0671,2581,3091,2901,3541,5091,639
Operating Profit 19202629292930425049506268
OPM % 2%2%3%3%3%3%3%3%4%4%4%4%4%
Other Income 21122913118765-4
Interest 13131418161710111010111214
Depreciation 576667778891010
Profit before tax 217781427353937364540
Tax % -44%490%6%23%16%-56%25%25%25%16%17%18%16%
Net Profit 4-46572121262931303734
EPS in Rs 8.05-9.0515.183.194.224.824.625.435.855.916.397.266.35

Last Updated: March 3, 2026, 10:02 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 4:50 am

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 1,3501,7732,5223,3003,9225,0966,020
Expenses 1,3261,7582,4983,2363,8104,9245,792
Operating Profit 23152464112172229
OPM % 2%1%1%2%3%3%4%
Other Income 51146143914
Interest 13202949664248
Depreciation 12162024253137
Profit before tax 4-11-20-436139159
Tax % 67%42%49%201%-12%23%
Net Profit 1-15-29-1140107132
EPS in Rs 93.81-1,550.90-77.71-28.128.9921.8025.91
Dividend Payout % 0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-1600.00%-93.33%62.07%463.64%167.50%
Change in YoY Net Profit Growth (%)0.00%1506.67%155.40%401.57%-296.14%

Entero Healthcare Solutions Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:30%
3 Years:26%
TTM:31%
Compounded Profit Growth
10 Years:%
5 Years:152%
3 Years:73%
TTM:94%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:%
1 Year:-17%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:6%

Last Updated: September 5, 2025, 3:26 pm

Balance Sheet

Last Updated: December 10, 2025, 4:15 am

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 0.100.1044434444
Reserves -16-32-62-731,5951,6811,723
Borrowings 6037209741,101338385443
Other Liabilities 162147210275369593642
Total Liabilities 7498361,1251,3082,3452,7032,851
Fixed Assets 186189262268289559627
CWIP 2210000
Investments 000005867
Other Assets 5606458631,0402,0562,0852,158
Total Assets 7498361,1251,3082,3452,7032,851

Reserves and Borrowings Chart

Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + -37-69-35-45-37-77
Cash from Investing Activity + -203-31-162-49-704232
Cash from Financing Activity + 2178921173863-74
Net Cash Flow -23-1114-2112282
Free Cash Flow -81-78-45-51-41-87
CFO/OP -134%-430%-100%-51%-21%-23%

Free Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-580.00-705.00-950.0063.00-226.00-213.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 635054575759
Inventory Days 575449414352
Days Payable 322222252431
Cash Conversion Cycle 888281737780
Working Capital Days 575441324865
ROCE %1%1%5%7%9%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 52.44%52.44%52.44%52.44%52.42%52.42%52.42%52.42%
FIIs 23.30%23.32%23.82%22.20%19.92%17.21%14.68%5.14%
DIIs 2.28%2.06%7.73%8.78%9.63%10.19%9.64%16.42%
Public 21.99%22.18%16.02%16.59%18.03%20.19%23.26%26.03%
No. of Shareholders 80,86466,40036,76733,17233,15933,33836,33440,333

Shareholding Pattern Chart

No. of Shareholders

Entero Healthcare Solutions Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Invesco India Contra Fund 1,577,379 0.82 162.79N/AN/AN/A
ICICI Prudential Value Fund 1,139,678 0.19 117.611,220,5842026-02-23 07:11:39-6.63%
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 961,455 1.46 99.22N/AN/AN/A
Invesco India ELSS Tax Saver Fund 246,100 0.98 25.4418,2012026-03-21 07:52:58-41.15%
Invesco India Aggressive Hybrid Fund 52,609 0.69 5.4330,0002026-01-25 04:58:4575.36%
Invesco India Equity Savings Fund 17,000 0.5 1.75N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 21.8010.81-3.10-9.22-5.29
Diluted EPS (Rs.) 21.7610.81-3.10-9.22-5.29
Cash EPS (Rs.) 31.7514.9031.94-25.1692.20
Book Value[Excl.RevalReserv]/Share (Rs.) 396.28377.38-160.39-144.87-3005.20
Book Value[Incl.RevalReserv]/Share (Rs.) 396.28377.38-160.39-144.87-3005.20
Revenue From Operations / Share (Rs.) 1171.23901.808025.806550.82177973.70
PBDIT / Share (Rs.) 48.5129.03169.0775.122547.60
PBIT / Share (Rs.) 41.4523.28110.1323.81920.00
PBT / Share (Rs.) 31.898.17-8.97-51.46-1083.80
Net Profit / Share (Rs.) 24.699.15-27.00-76.46-1535.40
NP After MI And SOA / Share (Rs.) 21.798.99-28.11-77.71-1553.70
PBDIT Margin (%) 4.143.212.101.141.43
PBIT Margin (%) 3.532.581.370.360.51
PBT Margin (%) 2.720.90-0.11-0.78-0.60
Net Profit Margin (%) 2.101.01-0.33-1.16-0.86
NP After MI And SOA Margin (%) 1.860.99-0.35-1.18-0.87
Return on Networth / Equity (%) 5.492.380.000.000.00
Return on Capital Employeed (%) 9.705.806.611.381.68
Return On Assets (%) 3.501.66-0.88-2.65-1.86
Long Term Debt / Equity (X) 0.000.02-0.45-0.640.00
Total Debt / Equity (X) 0.170.16-5.45-4.92-4.46
Asset Turnover Ratio (%) 2.022.152.712.570.00
Current Ratio (X) 2.463.341.641.842.19
Quick Ratio (X) 1.682.641.091.171.35
Inventory Turnover Ratio (X) 9.430.000.000.000.00
Interest Coverage Ratio (X) 5.071.921.420.991.27
Interest Coverage Ratio (Post Tax) (X) 3.581.610.77-0.010.23
Enterprise Value (Cr.) 5029.503669.420.000.000.00
EV / Net Operating Revenue (X) 0.980.930.000.000.00
EV / EBITDA (X) 23.8329.060.000.000.00
MarketCap / Net Operating Revenue (X) 0.971.090.000.000.00
Price / BV (X) 2.872.620.000.000.00
Price / Net Operating Revenue (X) 0.971.090.000.000.00
EarningsYield 0.010.010.000.000.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Entero Healthcare Solutions Ltd. is a Public Limited Listed company incorporated on 10/01/2018 and has its registered office in the State of Haryana, India. Company's Corporate Identification Number(CIN) is L74999HR2018PLC072204 and registration number is 072204. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 408.67 Cr. and Equity Capital is Rs. 43.51 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsPlot No. I-35, Building - B, Industrial Area, Phase - I, Faridabad Haryana 121003Contact not found
Management
NamePosition Held
Mr. Sujesh VasudevanChairperson (NonExe.&Ind.Director)
Mr. Prabhat AgrawalManaging Director & CEO
Mr. Prem SethiWhole Time Director & COO
Mr. Rajesh Shashikant DalalInd. Non-Executive Director
Ms. Sandhya Gadkari SharmaInd. Non-Executive Director
Mr. Arun SadhanandhamNon Exe.Non Ind.Director
Ms. Sumona ChakrabortyNon Exe.Non Ind.Director
Mr. Kevin Rohitbhai DaftaryNon Exe.Non Ind.Director

FAQ

What is the intrinsic value of Entero Healthcare Solutions Ltd and is it undervalued?

As of 14 April 2026, Entero Healthcare Solutions Ltd's intrinsic value is ₹941.93, which is 24.46% lower than the current market price of ₹1,247.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (5.63 %), book value (₹406), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Entero Healthcare Solutions Ltd?

Entero Healthcare Solutions Ltd is trading at ₹1,247.00 as of 14 April 2026, with a FY2026-2027 high of ₹1,511 and low of ₹944. The stock is currently in the middle of its 52-week range. Market cap stands at ₹5,424 Cr..

How does Entero Healthcare Solutions Ltd's P/E ratio compare to its industry?

Entero Healthcare Solutions Ltd has a P/E ratio of 46.6, which is below the industry average of 53.84. This is broadly in line with or below the industry average.

Is Entero Healthcare Solutions Ltd financially healthy?

Key indicators for Entero Healthcare Solutions Ltd: ROCE of 8.71 % is on the lower side compared to the industry average of 16.35%; ROE of 5.63 % is below ideal levels (industry average: 15.16%). Dividend yield is 0.00 %.

Is Entero Healthcare Solutions Ltd profitable and how is the profit trend?

Entero Healthcare Solutions Ltd reported a net profit of ₹107 Cr in Mar 2025 on revenue of ₹5,096 Cr. Compared to ₹-29 Cr in Mar 2022, the net profit shows an improving trend.

Does Entero Healthcare Solutions Ltd pay dividends?

Entero Healthcare Solutions Ltd has a dividend yield of 0.00 % at the current price of ₹1,247.00. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Entero Healthcare Solutions Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports